GCM
KYMR icon

Graham Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Graham Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,557
Closed -$304K – 1214
2024
Q1 		$304K Sell
7,557
-6,237
-45% -$223K 0.01% 781
2023
Q4 		$351K Buy
+13,794
New +$247K 0.01% 683
2023
Q3 		– Sell
-25,840
Closed -$594K – 1172
2023
Q2 		$594K Buy
+25,840
New +$740K 0.02% 506
2022
Q4 		– Sell
-101,001
Closed -$2.2M – 1186
2022
Q3 		$2.2M Buy
101,001
+70,238
+228% +$1.85M 0.09% 200
2022
Q2 		$605K Buy
30,763
+17,611
+134% +$411K 0.03% 607
2022
Q1 		$556K Buy
+13,152
New +$555K 0.03% 517

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return